{"id":52803,"date":"2026-03-31T21:00:00","date_gmt":"2026-03-31T14:00:00","guid":{"rendered":"https:\/\/thaipropertynews.com\/feeds\/?p=52803"},"modified":"2026-03-31T21:00:00","modified_gmt":"2026-03-31T14:00:00","slug":"dalton-pharma-services-expands-aseptic-powder-fill-finish-capacity-with-robofil-system-in-toronto","status":"publish","type":"post","link":"https:\/\/thaipropertynews.com\/feeds\/?p=52803","title":{"rendered":"Dalton Pharma Services Expands Aseptic Powder Fill-Finish Capacity with RoboFil\u2122 system in Toronto"},"content":{"rendered":"\n\n\n
\"\"<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

A fully automated aseptic fill-finish platform delivers greater speed, flexibility, and quality for the manufacturing of clinical supplies and commercial products.<\/b><\/p>\n

TORONTO<\/span>, March 31, 2026<\/span> \/PRNewswire\/ —\u00a0Dalton Pharma Services today announced the successful installation of its RoboFil\u2122 aseptic powder fill-finish system at its Toronto, Canada facility. This fully automated, isolator-based platform expands Dalton’s aseptic powder fill-finish capacity and further strengthens the company’s position as a market leader.<\/p>\n

\"Dalton's<\/a>
Dalton’s RoboFil\u2122 – Robotic Fill\/Finish<\/span> <\/div>\n

Dalton’s RoboFil\u2122 line<\/a> is purpose-built for aseptic powder fill-finish programs where dose accuracy, process consistency, and sterility assurance are paramount. By combining robotic handling with isolator technology, the platform helps minimize the needs for operator interventions, a primary contamination risk in aseptic operations, while enabling rapid, efficient changeovers between vial formats. This flexibility supports both development-stage batches through to repeatable GMP production campaigns.<\/p>\n

Dr. Jixing Wang, President of Dalton Pharma Services, said:<\/p>\n

“RoboFil\u2122 reflects Dalton’s commitment to investing in advanced technologies that enable our clients to execute aseptic powder fill-finish with confidence. This Annex 1\u2013aligned robotic isolator platform expands both our capacity and our operational flexibility, supporting programs from early clinical supply through scalable commercial manufacturing.”<\/i><\/p>\n

About Dalton Pharma Services:<\/b> Dalton Pharma Services is a full-service Contract Development and Manufacturing Organization (CDMO) based in Toronto, Canada. With 37 years of proven performance, Dalton’s single-site model integrates API development and cGMP manufacturing, formulation, aseptic fill\/finish, and in-house QC\/microbiological testing under a unified Quality Management System (QMS). Powered by a globally diverse team representing 40+ nationalities, including 44 MS\/PhDs, and supported by 3,000+ successful production campaigns, Dalton partners with biotech and pharmaceutical companies worldwide to accelerate life-enhancing therapies from development through commercial supply.<\/p>\n

For more information, visit: Dalton Website<\/a><\/p>\n

Media Contact<\/b>
Muhammad Haris
Marketing Manager
mharis@dalton.com<\/a><\/p>\n

\u00a0<\/p>","protected":false},"excerpt":{"rendered":"

<\/p>\n\n\n\n
\"\"<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

A fully automated aseptic fill-finish platform delivers greater speed, flexibility, and quality for the manufacturing of clinical supplies and commercial products.<\/b><\/p>\n

TORONTO<\/span>, March 31, 2026<\/span> \/PRNewswire\/ —\u00a0Dalton Pharma Services today announced the successful installation of its RoboFil\u2122 aseptic powder fill-finish system at its Toronto, Canada facility. This fully automated, isolator-based platform expands Dalton’s aseptic powder fill-finish capacity and further strengthens the company’s position as a market leader.<\/p>\n

\"Dalton's<\/a>
Dalton’s RoboFil\u2122 – Robotic Fill\/Finish<\/span> <\/div>\n

Dalton’s RoboFil\u2122 line<\/a> is purpose-built for aseptic powder fill-finish programs where dose accuracy, process consistency, and sterility assurance are paramount. By combining robotic handling with isolator technology, the platform helps minimize the needs for operator interventions, a primary contamination risk in aseptic operations, while enabling rapid, efficient changeovers between vial formats. This flexibility supports both development-stage batches through to repeatable GMP production campaigns.<\/p>\n

Dr. Jixing Wang, President of Dalton Pharma Services, said:<\/p>\n

“RoboFil\u2122 reflects Dalton’s commitment to investing in advanced technologies that enable our clients to execute aseptic powder fill-finish with confidence. This Annex 1\u2013aligned robotic isolator platform expands both our capacity and our operational flexibility, supporting programs from early clinical supply through scalable commercial manufacturing.”<\/i><\/p>\n

About Dalton Pharma Services:<\/b> Dalton Pharma Services is a full-service Contract Development and Manufacturing Organization (CDMO) based in Toronto, Canada. With 37 years of proven performance, Dalton’s single-site model integrates API development and cGMP manufacturing, formulation, aseptic fill\/finish, and in-house QC\/microbiological testing under a unified Quality Management System (QMS). Powered by a globally diverse team representing 40+ nationalities, including 44 MS\/PhDs, and supported by 3,000+ successful production campaigns, Dalton partners with biotech and pharmaceutical companies worldwide to accelerate life-enhancing therapies from development through commercial supply.<\/p>\n

For more information, visit: Dalton Website<\/a><\/p>\n

Media Contact<\/b>
Muhammad Haris
Marketing Manager
mharis@dalton.com<\/a><\/p>\n

\u00a0<\/p>\n

<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":[],"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[5,7],"tags":[],"class_list":["post-52803","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cision-pr-newswire","category-cision-pr-newswire-en"],"_links":{"self":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts\/52803","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=52803"}],"version-history":[{"count":0,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts\/52803\/revisions"}],"wp:attachment":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=52803"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=52803"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=52803"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}